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Abstract  16 
In bacteria, RNase III cleaves the initial long primary ribosomal RNA transcripts/precursors 17 
(pre-rRNAs), thereby releasing the pre-16S and pre-23S rRNAs for maturation. This cleavage 18 
is specified by the double-stranded secondary structures flanking the mature rRNAs, and not 19 
necessarily by the nucleotide sequences. Inhibition of this cleavage would lead to a build-up 20 
of pre-rRNA molecules. Doxycycline has earlier been shown to bind synthetic double-21 
stranded RNAs and inhibit their cleavage by RNase III. Since bacterial rRNA processing is 22 
primarily dependent on RNase III cleavage (which is inhibited by doxycycline), doxycycline 23 
could therefore inhibit the normal processing of bacterial rRNA. In this study, the effect of 24 
doxycycline on bacterial rRNA processing was investigated by analyzing the amounts of 25 
various rRNAs in growing E. coli cells treated with doxycycline. The results showed a 26 
doxycycline dose-dependent decrease in mature 16S and 23S rRNAs, concurrent with an 27 
accumulation of the initial rRNA transcripts and long precursors. Morphologically, treated 28 
cells were elongated at low drug concentrations, while nucleoid degeneration indicative of 29 
cell death occurred at higher drug concentrations. These observations suggest that 30 
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doxycycline inhibits the cleavage and processing of bacterial rRNA transcripts/precursors, 31 
leading to impaired formation of mature rRNAs, and the consequent inhibition of protein 32 
synthesis for which the tetracycline group of antibiotics are renowned. Since rRNA structure 33 
and processing pathway is conserved among bacterial species, this mechanism may account 34 
for the broad spectrum of antibiotic activity and selective microbial protein synthesis 35 
inhibition of doxycycline and the tetracyclines. 36 
Keywords: doxycycline/pre-rRNA/ribosomal RNA processing/RNase III 37 
cleavage/tetracycline antibiotics. 38 
Introduction 39 
Doxycycline is a member of the broad spectrum group of antibiotics known as the 40 
tetracyclines. The tetracyclines are known to inhibit bacterial protein synthesis by binding to 41 
the 16S ribosomal RNA (rRNA) and inhibiting the binding of aminoacyl-tRNA to the 42 
mRNA-ribosome complex [1-4]. However, their activity against other microbes which do not 43 
possess the 16S rRNA such as viruses, protozoa, and helminths has raised further questions 44 
as to the exact mechanism of action. In addition, despite conservation of ribosome structure 45 
and function between bacteria and host cells, the tetracyclines are sufficiently selective that 46 
the protein synthesis machinery of the host organism remains relatively unaffected. Despite 47 
their long history of usage as therapeutic agents, the mechanism(s) by which the tetracyclines 48 
achieve their wide range of effects and selectively inhibit microbial protein synthesis is not 49 
yet fully understood. 50 
Even though binding interactions with both the 16S and 23S rRNAs had earlier been 51 
indicated for the tetracyclines [5], an in vitro study to correlate ribosomal subunit activity 52 
with drug binding suggested that inhibition of tRNA binding to the A-site is solely due to 53 
tetracycline crosslinked to the strong binding site on the 30S ribosomal subunit [6]. Hence, 54 
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subsequent investigations on the mechanism of action of the tetracyclines and their 55 
interaction with ribosomal RNA concentrated on the 16S rRNA of the 30S ribosomal subunit 56 
[7]. Nevertheless, a recent study has shown that the tetracyclines (doxycycline and 57 
minocycline) bind to various synthetic double-stranded RNAs of random base sequence and 58 
inhibit their cleavage by RNase III in vitro [8]. This could imply that the double stranded 59 
secondary structures that frequently occur in cellular RNAs may be more crucial for the 60 
binding of the tetracyclines to RNA than the specific base pairs; and that the mechanism of 61 
action of the tetracyclines may be linked to the effect of the drugs on the processing of such 62 
cellular RNAs. If this is correlated in vivo, it could offer insights into the mechanism that 63 
underlie the activity of the tetracyclines against a wide range of pathogens, as well as in other 64 
non-infectious therapeutic indications of the drugs.  65 
Ribosomal RNAs constitute about 95% of total cellular RNA in E. coli [9]. They form the 66 
active sites of the ribosomes for decoding the message of the mRNA, as well as perform 67 
enzymatic functions in the translation process [10]. The rRNAs of prokaryotes are co-68 
transcribed from an operon (Fig 1), and E. coli has 7 copies of rRNA operons in the 69 
chromosome [11]. RNase III then cleaves the nascent rRNA transcripts at the double-70 
stranded stem regions that flank the mature 16S and 23S ribosomal RNA sequences to release 71 
the pre-16S and pre-23S rRNAs for further maturation [11-13]. In wild type cells, RNase III 72 
cleavage is very rapid, and occurs concurrently with transcription. Hence, only a very small 73 
amount of the long primary transcript (1-2% of total rRNA) is reported to be detectable in E. 74 
coli [14]. However, in RNase III-deficient strains, the 30S pre-rRNA accumulates [15]. In 75 
this study, the effects of doxycycline on the processing of bacterial ribosomal RNAs were 76 
investigated and correlated with their antibiotic activity in  growing E. coli cells, with a view 77 
to elucidate the molecular mechanism of their antimicrobial activity. 78 
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 79 
Materials and methods 80 
Probes and primers used in this study are listed in Table 1, and obtained from Sigma® 81 
Aldrich. Doxycycline was also purchased from Sigma® Aldrich. Nylon membranes were 82 
purchased from Roche (Roche # 11209299001). Hybridization probe labelling and detection 83 
was done using AlkPhos Direct™ labelling and detection System with ECF™ from GE 84 
healthcare life sciences (RPN3692). 85 
All procedures (sample collection, RNA extraction, gel electrophoresis, transfer to nylon 86 
membranes and northern blot hybridization) were performed at least in replicates of three 87 
independent experiments. 88 
 89 
Total RNA extraction 90 
An overnight culture of E. coli strain K-12 grown in LB broth was diluted 20 fold with fresh 91 
medium and incubated at 37
o
C in a Stuart orbital incubator S1500 with shaking for 1hr to 92 
ensure growth is activated. The culture was divided into aliquots to which were added 0-200 93 
µM doxycycline (0-96 µg/ml) and incubated at 37
o
C with shaking (180 rpm). Optical density 94 
(OD) of cultures was measured at 550nm using Biotek Powerwave XS universal spectrometer. 95 
2 ml of culture samples were taken from each treatment group at the indicated time points (0-96 
240 min). Nucleic acid decay was stopped in collected samples by immediate transfer of the 97 
samples to a cold microcentrifuge tube (on ice) containing 200 µl ethanol and 20 µl phenol 98 
[16]. The bacterial cells were harvested by centrifuging at 8000 rpm for 1 min, and lysed by 99 
re-suspending the pellet in 400 µl of Sigma B cell lysis reagent (Sigma® Aldrich). Total 100 
RNA was harvested by the phenol-chloroform extraction method with ethanol precipitation 101 
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[17]. 400 µl phenol (Sigma) was added to the samples and the tube vortexed vigorously for at 102 
least 2 min total. 400 µl RNase-free water and 400 µl chloroform (Sigma) was then added 103 
and vortexed vigorously for another 2 min. The tube was then centrifuged at 12000 rpm for 104 
15 min and 600 µl of the aqueous phase transferred to a fresh 2 mL tube. 60 µl of 3 M 105 
sodium acetate and 1.4 ml ethanol was added, mixed and held on ice for 10 min, and 106 
centrifuged at 10000 rpm in a microcentrifuge for 15 min. The supernatant was removed, and 107 
the pellet rinsed with 70% ethanol and dried. The resultant nucleic acid pellets were 108 
resuspended in 1x TE buffer (10 mM Tris, pH 8.0, 1 mM EDTA) and stored at -20
o
C until 109 
further use. The nucleic acid concentration of the extracts was quantified using NanoDrop 110 
ND-1000 spectrophotometer, and scored as an average of at least three readings. 111 
Northern blot analysis of mature rRNA from E. coli total RNA extract 112 
Ribosomal RNA was separated from the total RNA extracts by agarose gel electrophoresis. 5 113 
µl total RNA extracts from each sample was loaded in 1% agarose gels containing 1X MOPS 114 
buffer. For denaturing gel electrophoresis, the RNA samples were incubated with 3X volume 115 
of formaldehyde loading dye (Ambion) at 65
o
C for 10 min before loading. Electrophoresis 116 
was carried out at 90 V for 40 min in 1X MOPS buffer and gels were stained with 1X EtBr or 117 
SYBR® Gold (Invitrogen™). Images were taken with SynGene G:Box camera using 118 
GeneSnap software. The rRNA was subsequently transferred unto positively charged nylon 119 
membranes by gravity and capillary action. The gel was soaked in 20X saline-sodium citrate 120 
(SSC) buffer for 30 min, placed right side up on the nylon membrane without trapping air 121 
bubbles in-between and covered on both sides with Whatman filter paper that had been cut to 122 
size and soaked in 20X SSC buffer. The gel was wrapped around the edges with parafilm to 123 
prevent drying and ensure that transfer proceeds only through the gel. About 2 cm of paper 124 
towel was also cut to size, soaked in 10X SSC buffer and placed on top of the filter paper. A 125 
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small flat weight was then placed on top of the stack which was allowed to stand overnight.  126 
After overnight transfer, the membrane was rinsed with 2X SSC buffer and air-dried. RNA 127 
was cross-linked to the membrane by UV illumination for 1-1.5 min using SynGene G:Box 128 
transilluminator. Membranes were then stained with 2% methylene blue and de-stained in 2% 129 
SSC buffer to check for mature rRNA bands (visible to the naked eye). Images were taken 130 
using SynGene G:Box image camera. Membranes were subsequently stored dry at 4
o
C until 131 
used for hybridization. 132 
Probe design 133 
CCPR1 was designed to target a sequence 21 base pairs from the 3’ end of E. coli K-12 16S 134 
rRNA, and purchased from Sigma. CCPR2 was designed to target the sequence between 10 135 
bp downstream of K-12 16S rRNA and 10 bp upstream of 23S rRNA, including the 136 
intergenic sequences (Fig 1B). BLAST search (Basic Local Alignment Search Tool, NCBI) 137 
indicated no similarity to any other E. coli gene segment apart from the ribosomal RNA. 138 
CCPR2 was synthesized by PCR amplification using the primers shown on Table 1. The 139 
amplicon size was verified by matching the band of the PCR product on agarose gel 140 
electrophoresis with the band of DNA ladder of the expected size. 141 
Nucleic acid hybridization for detection of pre-rRNAs 142 
The probe was labelled with alkaline phosphatase using AlkPhos Direct™ labelling and 143 
detection System with ECF™ (GE healthcare life sciences) following the manufacturer’s 144 
instructions. For this experiment, a ten-fold dilution of overnight culture of E. coli K12 cells 145 
was grown to exponential phase for about 1.5 hrs in LB broth (to ensure a high cell 146 
harvest/rRNA yield) before adding doxycycline at the specified concentrations. The cultures 147 
were then incubated for only 20 min to minimize the differential inhibitory effects of the 148 
antibiotic concentrations on culture growth (OD) and concentration of the RNA extracted. 149 
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Hence, samples were collected at 20 min incubation time. The total RNA was extracted and 150 
separated by gel electrophoresis, then transferred onto nylon membranes. Membrane blots of 151 
the total RNA extracts were equilibrated in hybridization buffer for 15 min before overnight 152 
hybridization with the labelled probe in a hybridization oven at 42
o
C. Membranes were 153 
washed at 42
o
C with the primary wash buffer, and at room temperature with the secondary 154 
wash buffer. Detection reagent was applied to the membranes, which were then wrapped with 155 
cling film and incubated overnight in the dark to enhance development of the fluorescence 156 
signal. Blots were scanned and images were taken using SynGene G:Box camera.  157 
Fluorescence microscopy 158 
E. coli strain K-12 was grown in LB broth containing 0-200 µM doxycycline at 37
o
C for 20 159 
min. Cells were harvested by centrifuging and washed twice with 2x volume of 1x PBS. They 160 
were stained using DAPI (to examine the nucleoid morphology) by adding 1x volume of 1 161 
µM DAPI (Sigma) and incubating in the dark for about 5 min. Samples were then mounted 162 
on glass slides with cover slips. Cell morphology was examined with Leica DM4000B 163 
fluorescence microscope using DAPI filter. Images were captured with DC500 camera using 164 
Leica IM500 software programme. 165 
Data Analysis 166 
All RNA band intensities were quantified using the image analysis software, GeneTools from 167 
SynGene (Cambridge, UK). Statistical analysis was done using GraphPad Prisms 7.02. 168 
Means were compared using repeated measure ANOVA or paired t-test (as appropriate), 169 
while dose-response effects were analysed using non-linear regression fitted for direct (non-170 
normalized) response. Statistical significance was considered at 95% confidence interval (P 171 
≤0.05 significance level).  172 
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Results 173 
 174 
Doxycycline reduces the amounts of mature ribosomal RNA in vivo 175 
In view of earlier reports that doxycycline inhibits RNase III degradation/cleavage of double-176 
stranded RNA  in vitro [8], the effect of doxycycline on RNase III-dependent dsRNA 177 
cleavage/processing pathways in vivo was investigated. The most important and generalized 178 
RNase III-dependent processing pathway in bacteria cells with respect to protein synthesis is 179 
the processing of ribosomal RNA. RNase III cleavage is the rate limiting step for the 180 
formation of mature rRNAs which is necessary for protein synthesis in growing bacteria cells. 181 
To assess the effect of doxycycline on this processing pathway in vivo, total RNA was 182 
harvested from doxycycline-treated and untreated E. coli K-12 cells and analysed by native 183 
agarose gel electrophoresis. The intensities of the mature ribosomal RNA bands in the cells 184 
growing in the presence of 100µM doxycycline over a given time was compared with those 185 
of cells growing in the absence of the drug. The results show a significant (P= 0.0046 for 23S 186 
and 0.0091 for 16S rRNA) and progressive reduction (r = -0.7365 for 23S and -0.8126 for 187 
16S rRNA) in the band intensities of mature ribosomal RNAs over time in the cells growing 188 
with doxycycline, in contrast to those growing without the drug, which showed a progressive 189 
increase in rRNA band intensities that peaked at about 210 min (Fig 2). In the sample 190 
containing doxycycline, there was a sharp drop in the band intensities of the 16S and 23S 191 
ribosomal RNAs at 20 min, which subsequently increased slightly between 40-90 min before 192 
ultimately fading away. When gels of samples containing other concentrations of doxycycline 193 
(2-200µM) over time were analysed, it was observed that this sharp drop in the band 194 
intensities of the 16S and 23S rRNAs at 20 min only occurred at higher doxycycline 195 
concentrations (100-200µM); but at lower doxycycline concentrations (0-50µM), the 196 
10 
 
decrease is gradual and steady. These results suggest that doxycycline inhibits the formation 197 
of mature rRNAs, although the inhibition of bacterial growth in the presence of the drug may 198 
contribute to this effect. 199 
 200 
To determine whether the observed depletion of 16S and 23S rRNAs in doxycycline-treated 201 
samples was caused by inhibited rRNA formation due to processing rather than inhibited 202 
synthesis due to growth inhibition or death of bacteria cells, the RNA samples were also 203 
analysed by northern blot hybridization to detect the pre-16S rRNA (using CCPR1 probe). If 204 
the reduction in mature rRNA band intensities seen in Fig 2A was simply due to reduced cell 205 
numbers by the growth inhibitory activity of the drug, one would expect a commensurate and 206 
concurrent reduction in the amounts of pre-rRNA detected by northern blotting. However, 207 
northern blot hybridization assay of the samples showed the presence of long pre-rRNAs in 208 
both treated and untreated samples, with no significant difference (P= 0.7157) between the 209 
treated and untreated groups (Fig 2B). There was no reduction in pre-rRNA band intensity in 210 
doxycycline-treated cells. Instead, there was smearing of the pre-rRNA bands in doxycycline-211 
treated cells from earlier incubation time points (20-60 min), indicating the presence of 212 
variable sizes of pre-16S rRNA in all doxycycline-treated samples. This smearing only 213 
occurred at longer incubation times (120-240 min) in untreated samples. These results 214 
suggest that rRNA was still being transcribed in doxycycline-treated cells at all time points 215 
studied, but the rRNA transcripts and pre-rRNA were not adequately processed to form the 216 
mature 16S and 23S rRNAs. 217 
Interestingly, in the course of these experiments, some samples were analysed by denaturing 218 
gel electrophoresis that was run much longer (2-4hr) to allow a better separation of the RNA 219 
bands. In these experimental conditions, we observed a difference in the profile of the long 220 
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pre-rRNA bands between the samples that contain doxycycline and those without the drug.  221 
Whereas only one band was seen in the samples without the drug from about 60 min, the 222 
samples containing the drug showed an additional second band from about 210 min 223 
incubation time which represents different species/sizes of the long pre-rRNA. Since the pre-224 
rRNA are cleavage products of the initial transcripts, the observation of different pre-rRNA 225 
sizes between doxycycline-treated and untreated cells is suggestive of impaired/abnormal 226 
cleavage or processing of the rRNA transcripts in the presence of doxycycline. 227 
 228 
Doxycycline induces a dose-dependent inhibition of mature ribosomal RNA in growing 229 
bacteria cells 230 
In order to further investigate the involvement of doxycycline in the observed reduction in the 231 
amounts of mature ribosomal RNA in E. coli K-12 cells, total RNA from cells grown in the 232 
presence of various concentrations of doxycycline was assessed. Samples collected at both 20 233 
and 120 min of incubation time showed a dose-dependent decrease in the amounts of mature 234 
16S and 23S rRNA with increasing amounts of doxycycline (Fig 3). Statistical analysis 235 
showed that the concentration of doxycycline that gave a response half-way between baseline 236 
and maximal (IC50) at 20 min incubation time was 8.327µM (+/-SE 2.465, R
2
= 0.9554), and 237 
within the range of 4.295-17.95 µM at 95% confidence interval (CI). This increased at 120 238 
min incubation time to 76.51 µM (+/-SE 49.6, R
2
= 0.8947), and within 24.05-392.6 µM at 239 
95% CI. IC95 was observed at 100 µM doxycycline concentration, which had the lowest 240 
rRNA band intensity observed at both 20 and 120 min incubation times. The lower 241 
concentrations of doxycycline (2-20 µM) showed a slight increase in the intensity of mature 242 
rRNA bands at the longer incubation time (Fig 3A, 120 min). Further analysis of samples at 243 
increasing incubation time of different doses showed that this increase in mature rRNA band 244 
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intensity at lower concentrations of doxycycline was sustained over the duration of the 245 
experiments (240 min), and was highest at the lowest concentration of doxycycline used (2 246 
µM). This suggests that sub-inhibitory concentrations of doxycycline may induce rRNA 247 
formation/synthesis with time. In addition, there was also a general increase in the total RNA 248 
concentration of doxycycline treated samples at 120 min compared to the untreated samples 249 
(which was highest at 5 µM drug concentration; Fig 3F), despite decreased culture 250 
growth/OD at that incubation time (Fig 3E). However, in spite of the fact that the higher drug 251 
concentrations (50-200 µM) had higher total RNA concentration than the untreated cells at 252 
120 min incubation time (Fig 3E), they still showed decreased 16S and 23S rRNA band 253 
intensities in the gel (Fig 3A). This suggests that much of the RNAs at these drug 254 
concentrations are not mature rRNA. The growth curves also showed that all drug 255 
concentrations produced similar growth inhibitory effects at 20 min incubation time, but had 256 
variable effects at longer incubation times. At 120 min incubation time, the maximum growth 257 
inhibition was achieved with 10-20 µM (Fig 3E). These results therefore indicate that the 258 
effect of doxycycline on the formation of rRNAs in growing bacteria cells is affected by both 259 
drug dosage and incubation/treatment time, and that very low doses of doxycycline may 260 
induce rRNA transcription/formation over time. 261 
When the samples were analysed by northern blot hybridization to detect pre-16S rRNA 262 
using CCPR1 probe (Fig 3B), the intensity of the long rRNA precursors (initial transcript and 263 
pre-rRNA) increased with increasing drug concentration at 20 min incubation time, with 264 
smearing at the lower drug concentrations (2-20 µM). This indicates that more pre-16S rRNA 265 
is being retained in the long precursors with increasing drug concentration.  At 120 min, all 266 
the rRNA bands (except the rRNA transcript band) were smeared. Besides smearing, the pre-267 
rRNA bands became faint whereas the mature rRNA bands became more prominent at 120 268 
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min, especially at lower drug concentrations (2-20 µM) when compared to the 20 min 269 
samples. This indicates that the pre-rRNA was being cleaved (albeit inadequately) into 270 
smaller particles about the size of the mature 16S and 23S rRNAs with time, especially at low 271 
drug concentrations.  This is consistent with the observed increase in band intensities of the 272 
16S and 23S rRNAs at these low drug concentrations and longer incubation time in the gel 273 
image (Fig 3A).  Altogether, these results suggest that the inhibition of mature rRNA 274 
formation by doxycycline could be due to inadequate cleavage/processing of the long rRNA 275 
transcripts and pre-rRNAs. 276 
 277 
Doxycycline induces accumulation of pre-rRNAs in growing bacteria cells 278 
The observation that doxycycline inhibits RNase III cleavage of total RNA extracts in vitro 279 
and the formation of mature rRNAs in vivo could imply that the drug inhibits the cleavage 280 
and processing of the primary rRNA transcripts and pre-rRNA. If this is true, then 281 
doxycycline would induce accumulation of the unprocessed pre-rRNAs. This would 282 
substantiate the decrease in 16S and 23S rRNA bands as resulting from the effect of the drug 283 
on ribosomal RNA processing, rather than just a reflection of the rate of culture growth. 284 
Hence, the effect of doxycycline on the cleavage/processing of the primary ribosomal RNA 285 
transcript was further investigated in vivo by northern blot hybridization assay to assess the 286 
amounts of long primary rRNA transcripts and pre-rRNAs in growing bacteria cells treated 287 
with various concentrations of doxycycline. To minimize the growth inhibitory effect of the 288 
antibiotic and ensure good RNA yield in this experiment, bacterial cultures were initially 289 
grown to exponential phase before treatment, and thereafter, samples were harvested at 20 290 
min incubation time to minimize differential growth in the antibiotic media (culture OD and 291 
total RNA extract concentrations were also assessed for confirmation). A probe (CCPR2) that 292 
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is complementary to the spacer region between the mature 16S and 23S rRNAs (including 293 
about 10 nucleotides upstream and downstream as shown in Fig 1) was used to detect 294 
uncleaved rRNA transcripts and long pre-rRNAs in the total RNA extracts. If rRNA 295 
processing occurs normally, this region is cleaved off by RNase III, and further processing 296 
yields mature 16S and 23S rRNAs. If RNase III cleavage is inhibited, this region is retained 297 
and would accumulate in the initial transcripts and long pre-rRNA. 298 
Northern blot hybridization assay of the total RNA extracts from cells grown in the presence 299 
of various concentrations of doxycycline for 20 min (using the probe CCPR2) showed a dose-300 
dependent accumulation of the initial transcripts and long pre-rRNA species, concomitant 301 
with a dose-dependent decrease in the 16S and 23S rRNA species (Fig 4). There were two 302 
distinct bands representing two uncleaved long rRNA precursors detected by the probe: a 303 
long initial rRNA transcript (positioned just below the wells), and a long pre-rRNA 304 
(estimated to be about 9KB in size). Linear regression analysis of culture OD showed no 305 
significant change in the culture OD (P= 0.7745). For total RNA concentration, 50% of the 306 
observed reduction was induced at about 192µM doxycycline concentration (IC50 at 307 
R
2
=0.8534). Despite the culture OD being stable at all drug concentrations, and decreasing 308 
total RNA concentrations from 50-200µM drug concentrations (Fig 4C), both the initial 309 
rRNA transcript and the pre-rRNA band intensities increased with increasing doxycycline 310 
concentration (Fig 4D). It is interesting to note that the highest pre-rRNA band intensity 311 
occurred at doxycycline concentrations at which total RNA concentrations decreased. These 312 
observations strongly indicate that the effects of doxycycline on rRNA band intensities may 313 
be due to inhibition of rRNA transcript processing, and not essentially a reflection of culture 314 
growth inhibition by the antibiotic. 315 
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When the RNA band intensities were quantified by densitometry, statistical analysis of the 316 
results showed that 27.21 (+/- 19) µM doxycycline concentration (or 8.832-104.2 µM at 95% 317 
CI, R
2
=0.7949) induced 50% of the observed accumulation of pre-rRNAs (EC50). On the 318 
other hand, 4.149 (+/- 1.535) µM doxycycline concentration induced 50% of the observed 319 
reduction in 16S and 23S rRNAs (2.028-8.553 µM at 95% CI, R
2
=0.9596). It should be noted 320 
that the 16S and 23S rRNAs detected in this experiment are not yet fully mature (as they still 321 
contain some base sequences that are excised at maturation, which is detectable by the probe), 322 
and may differ slightly from the fully matured ones described in the previous sections. The 323 
concurrent increase in precursor rRNA species and decrease in 16S and 23S rRNAs indicates 324 
that much of the rRNAs are increasingly present as long precursor rRNAs with increasing 325 
doxycycline concentration. This reaches a peak at the higher drug concentrations (50-200µM) 326 
when only about 10% of the rRNA detected by the probe is in the 16S and 23S rRNA bands 327 
(Fig 4D inset). Taken together, these results indicate that doxycycline induces accumulation 328 
of uncleaved/long rRNA precursors, while inhibiting the formation of 16S and 23S rRNAs. 329 
This implies that doxycycline inhibits the cleavage of the rRNA transcripts and pre-rRNA 330 
into the smaller 16S and 23S fragments. 331 
 332 
Doxycycline induces bacterial cell elongation 333 
In order to correlate the molecular observations of the effects of doxycycline on ribosomal 334 
RNAs with the effect of the drug on the whole bacteria cell in vivo, the nucleoid morphology 335 
of cells treated with increasing concentrations of doxycycline for 20 min was examined. The 336 
results show that doxycycline induces elongation of bacteria cells at low doses (≤50µM), 337 
which is indicative of cell division inhibition. At higher drug concentrations, nucleoid 338 
degeneration was observed, which is indicative of early stages of cell death (Fig 5). This is 339 
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consistent with the observed decrease in total RNA concentration at 50-200µM doxycycline 340 
concentration, suggesting that bacterial cell death occurs at high drug concentrations. 341 
 342 
Discussion 343 
The currently held 16S rRNA binding mechanism of action of the tetracyclines so far have 344 
not been sufficiently correlated with in vivo effects of the drug and their wide range of 345 
antimicrobial (not just antibacterial) activities [18]. The recently reported double-stranded 346 
RNA binding may therefore be a mechanism worth investigating to help elucidate the 347 
molecular basis of their wide range of activities [8]. If the tetracyclines bind to dsRNA and 348 
inhibit their cleavage/degradation by RNase III as previously reported [8], it could induce the 349 
accumulation of rRNA transcripts/precursors in growing bacteria cells. 350 
The results presented here show a dose-dependent reduction of 16S and 23S rRNAs, 351 
concurrent with the accumulation of long rRNA precursors by doxycycline. Although any 352 
antibiotic that causes a reduction in bacterial growth would result in fewer cells growing in a 353 
culture medium, the observations in this study cannot be merely attributed to the growth 354 
inhibitory effects of an antibiotic. Several factors point towards a specific effect of 355 
doxycycline on mature rRNA formation rather than a reflection of the amount of cells in the 356 
culture. For instance, these effects were mostly observed at 20 min incubation time, when the 357 
effect of the drug on culture growth (OD) and total RNA concentration was minimal. 358 
Particularly, the greatest increase in pre-rRNA band intensity (Fig 4) occurred at drug 359 
concentrations at which there was a decrease in total RNA concentration (50-200µM). Even 360 
the cell morphology changes, which are consistent with the molecular observations and 361 
earlier reports for tetracycline [19], were also observed at 20 min incubation time. Moreover, 362 
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the increase in mature rRNA band intensities of low drug concentrations at longer incubation 363 
periods (120mins) when the growth inhibitory effects of the drug should have been more 364 
pronounced (Fig 3 A, D) indicate an effect on rRNA processing rather than culture growth. 365 
This is in agreement with earlier reports that Chlortetracycline induces initial stimulation of 366 
RNA synthesis especially at low concentrations, and subsequent accumulation of RNA while 367 
inhibiting protein synthesis [20, 21]. These reports suggested that the accumulated RNA 368 
species differ from both 23S and 16S rRNAs in their sedimentation properties (attributed to 369 
“incomplete precursors”), but could synthesize ribosomes during recovery from the antibiotic 370 
effects. In this study, the concurrent decrease in mature rRNAs and increase in precursor 371 
rRNAs as detected by northern blot hybridization (Fig 4D) indicate effects on rRNA 372 
processing by doxycycline. Furthermore, the observations of smeared pre-rRNA bands at 373 
longer incubation periods which decrease in intensity as the mature rRNAs increase in 374 
intensity (Fig 3B) also indicate effects on rRNA cleavage/processing. In view of the ability of 375 
doxycycline to inhibit RNase III degradation/cleavage of dsRNA [8], these results indicate 376 
that doxycycline inhibits the cleavage of long rRNA transcripts/precursors by RNase III; 377 
leading to the accumulation of the pre-rRNAs [15]. This initial inhibition of cleavage of the 378 
long rRNA precursors by doxycycline is subsequently relieved with time (Fig 3), as has also 379 
been demonstrated in vitro with synthetic dsRNA [8]. A combination of this subsequent 380 
recovery from the inhibitory effects of doxycycline with time and possible alternate 381 
processing pathway which is less efficient than the RNase III cleavage pathway [15, 22], 382 
would lead to improved processing of the rRNA precursors at longer incubation periods. This 383 
could explain the observation of increased mature rRNA band intensities at longer incubation 384 
time with lower drug concentrations (Fig 3A). The dose-dependent increase in the long rRNA 385 
precursors (Fig 4B) seems to suggest that doxycycline also stimulates rRNA transcription. 386 
This may occur via a positive feedback mechanism, as the transcribed rRNA is not being 387 
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processed to yield functional mature rRNA. Such feedback mechanisms involved in 388 
transcriptional regulation have been described in bacteria [23-25], and have recently been 389 
associated with the regulation of rRNA transcription [26]. On the other hand, it is unlikely 390 
that the inhibition of mature rRNA formation was due to inhibition of transcription. If that 391 
was so, one would expect a decrease in the initial rRNA transcript amounts. However, the 392 
reverse was the case in this study (Fig 3B, 4B&D), indicating the possibility of a positive 393 
feedback mechanism instead. The general picture appears to be like this: As doxycycline is 394 
added, the mature rRNA decreases and the cells react to the shortage of mature rRNas by 395 
increasing rRNA transcription. At higher doxycycline concentrations, more 396 
uncleaved/unprocessed pre-rRNA accumulate, and the cells activate/enhance alternative 397 
cleavage/processing pathways (such as by other nucleases) in an attempt to clear the 398 
accumulating pre-rRNAs. 399 
It has been reported that although RNase III cleavage is necessary for the maturation of 400 
23S rRNA, it is not essential for its function [27]. On the other hand, maturation of 16S 401 
rRNA could proceed in the absence of RNase III cleavage, as has been demonstrated in 402 
RNase III-deficient strain, even though such strains are known to grow slowly [28]. This is 403 
believed to be due to an alternative processing pathway in the absence of RNase III by other 404 
nucleases acting independently of RNase III [29, 30]. However, unlike the immature 23S 405 
rRNA which is functional in protein synthesis, the immature 16S rRNA is not functional in 406 
protein synthesis [28]. In this study, doxycycline was found to inhibit the amounts of both the 407 
16S and 23S rRNAs. It is therefore possible that the non-functionality of the immature 16S 408 
rRNA, in contrast to the functionally active immature 23S rRNA, led to the previous belief 409 
that the tetracyclines exert their antibacterial action solely by binding to the 16S rRNA [6].  410 
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It is interesting to note that the inhibitory effects of doxycycline on rRNA processing were 411 
observed at the effective antibacterial concentrations of the drug. MIC of doxycycline for E. 412 
coli K-12 and the range of plasma concentrations following clinical therapeutic usage is ≈4-413 
8µg/ml (≈10-20µM). However, drug concentrations in organs may reach 10-25 times that of 414 
serum [31]. Also, time-kill studies have shown that doxycycline exhibits time-dependent 415 
antibacterial effect on E. coli at low concentrations (2-4 times the MIC), but optimal dose-416 
dependent killing is achieved at higher drug concentrations of about 8-16 times the MIC [32]. 417 
This complex interplay of dose and time was also observed in this study on the effect of 418 
doxycycline on mature rRNA formation (Fig 3), and could have clinical implications for the 419 
effective use of doxycycline and other tetracycline antibiotics. Also, mutations in the 16S 420 
rRNA sequence that have been shown to confer resistance to tetracycline often occur at the 421 
double-stranded stem regions, and disrupt base pairing and formation of the secondary 422 
structures necessary for RNase III recognition and cleavage [33].  423 
The broad spectrum of antibacterial activity of the tetracyclines can be attributed to the 424 
highly conserved nature of rRNA processing via RNase III cleavage pathway among 425 
prokaryotes. In eukaryotes however, the processing of the ribosomal RNA involves a much 426 
more complex pathway that is not dependent on RNase III [34]. In addition, eukaryotic rRNA 427 
processing, occurs in a protected environment (nucleolus) where ionic conditions (especially 428 
Mg
2+
/divalent metal ion concentrations) are not ideal for doxycycline binding [8]. These 429 
differences in the processing pathway of prokaryotic and eukaryotic ribosomal RNAs could 430 
account for the selective inhibition of microbial protein synthesis, with minimal effects on 431 
eukaryotic protein synthesis [18]. The recovery from the inhibitory effects of the drug on the 432 
formation of mature ribosomal RNA with time supports the bacteriostatic mode of action of 433 
the tetracyclines. 434 
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Although the results presented here for doxycycline slightly digress from the 16S rRNA 435 
binding mechanism of action currently held for the tetracycline antibiotics, many of the 436 
underlying principles have been indicated long ago for various tetracyclines [5, 13, 19-21, 35-437 
37]. However, those leads seem to have been largely ignored in favour of certain postulations 438 
from in vitro studies [6, 18]. Nevertheless, this work would serve as a basis for further studies 439 
with other tetracycline antibiotics in this perspective. When correlated with their effects on 440 
non-bacterial and eukaryotic rRNA processing and non-infectious disease conditions, the 441 
molecular mechanism of action of the tetracyclines would be more definitively elucidated. 442 
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TABLES 571 
Table 1: Hybridization probes used for pre-rRNA northern blotting 572 
Probe/primer Target description* Length Sequence Reference 
ECR2 Mature 16S rRNA 28 5'-gtccccctctttggtcttgcgacgttat-3' [38] 
ECPR2 3’ pre-16S rRNA tail 
(rrnA, -D, -G, -H) 
30 5'-gtgtgagcactgcaaagtacgcttctttaa-3' [38] 
CCPR1  Pre-16S rRNA (3’ 
rrnA, -H; 5’ –D, -G) 
50 5’-cctgtagaggttttactgctcattttca 
tcagacaatctgtgtgagcact-3’ 
This work 
CCPR2 Pre-rRNA (3’ end of 
16S to 5’ end of 23S) 
457 * This work 
CCPR2 forward 
primer 
3’ end of 16S rRNA 22 5’-cacctccttaccttaaagaagc-3’ This work 
CCPR2 reverse 
primer 
5’ end of 23S rRNA 19 5’-tcgcttaacctcacaaccc-3’ This work 
*See Fig 1B for illustration of region of complementarity with target pre-rRNA. 573 
574 
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FIGURES, TITLES AND LEGENDS TO FIGURES 575 
 576 
Fig 1: Schematic representation of the primary transcript of ribosomal RNA of E. coli. 577 
(A) Mature rRNA sequences are indicated as bold line loops, and dsRNA within the 578 
precursor sequences represented by the stems (not drawn to scale). Arrows indicate proposed 579 
regions of double-stranded primary transcript RNase III cleavage sites, where cleavage 580 
releases the pre-16S and pre-23S rRNAs for further maturation to produce mature rRNAs. 581 
The * and ** symbols indicate the number of tRNA molecules within the operon at the 582 
indicated sites. * = 1 - 2, ** = 0 - 4. In addition, the rrnD in E. coli has two genes encoding 583 
5S rRNA. (B) Target position of the hybridization probes in relation to the mature ribosomal 584 
RNAs in the long primary rRNA transcript of E. coli. 585 
 586 
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 587 
Fig 2: Effect of doxycycline on mature rRNA amounts and rRNA sizes in growing 588 
bacteria cells over time. Northern blot membrane stained with methylene blue (A) of total 589 
RNA extract from E. coli cells growing in the absence and presence of 100µM doxycycline at 590 
various time points during growth showing the 23S and 16S rRNAs, and the hybridized 591 
membrane blot (B) showing rRNA primary transcript and pre-rRNA (that indicate continued 592 
transcription of rRNA) and smearing of the pre-rRNA in the presence of doxycycline. 593 
Graphical analysis of the rRNA band intensities (C,D) show significantly decreasing amounts 594 
of 16S and 23S rRNAs with time (P= 0.0046, r = -0.7365 for 23S, and P= 0.0091, r =  -595 
0.8126  for 16S rRNA) in cells that were grown in medium containing doxycycline, when 596 
compared to the increasing amounts of the rRNAs in cells growing without the drug. RFU= 597 
Relative fluorescence unit.  598 
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 599 
 600 
Fig 3: Effect of increasing concentrations of doxycycline on mature rRNA formation in 601 
growing bacterial cells. EtBr-stained denaturing agarose gel image (A) of total RNA 602 
extracted from E. coli cells grown in increasing concentrations of doxycycline (0-200µM) at 603 
20 min and 120 min incubation periods, showing decreasing amounts of 23S and 16S 604 
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ribosomal RNAs with increasing concentration of doxycycline as illustrated in the graphs (C, 605 
D), hybridized membrane blot of the gel (B) showing smearing of the RNA bands at 120 min, 606 
growth curve (E) and total RNA concentration of the samples (F).  IC50= 8.327µM (+/-SE 607 
2.465, R
2
= 0.9554) at 20 min incubation time and 76.51 µM (+/-SE 49.6, R
2
= 0.8947) at 608 
120min. RFU= Relative fluorescence unit, T=rRNA transcript. 609 
 610 
 611 
Fig 4: Effect of increasing concentrations of doxycycline on the processing of E. coli 612 
rRNA in vivo. (A) EtBr-stained denaturing agarose gel of total RNA extract from E. coli K-613 
12 cells grown in increasing concentrations of doxycycline. Samples were collected 20 min 614 
after treating with doxycycline, and total RNA extracted from the samples were fractionated 615 
in 1% denaturing agarose gel. S=starting culture sample at 0 min, 0=untreated culture at 616 
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20mins, M=NEB log 2-log DNA ladder (0.1-10.0 kb). (B) Northern blot nylon membrane 617 
hybridized with pre-rRNA probe CCPR2 showing the initial rRNA transcript (T) and long 618 
pre-rRNA. (C)Graphical presentation of the optical density of cultures and the concentration 619 
of total RNA extracted from them, showing no significant change in culture OD (P= 0.7745), 620 
and a slight decrease in RNA conc, from 50 µM doxycycline conc. S=starting culture sample 621 
at 0 min, 0=untreated culture at 20mins. (D) Graph of densitometric analysis of the various 622 
rRNA bands in B. The blot and graph show a dose-dependent increase in the long pre-rRNAs 623 
and concurrent decrease in 16S and 23S rRNAs with increasing doxycycline concentrations. 624 
RFU= Relative fluorescence unit. Inset shows percentage contribution of each rRNA species, 625 
as detected with the probe. 626 
 627 
 628 
30 
 
Fig 5: Effect of doxycycline on nucleoid morphology of E. coli. Fluorescent microscopy 629 
images of E. coli K-12 cells treated with 0-200µM doxycycline and incubated for 20 min 630 
before sample collection and processing for microscopy. Cells appear elongated at 20 and 50 631 
µM doxycycline, with nucleoid degeneration at 100-200µM. (x630). 632 
 633 
 634 
